
Matteo Santoni
@matteosantonimd
ID: 1859545098507464704
21-11-2024 10:31:23
23 Tweet
28 Takipçi
54 Takip Edilen

The never ending story. An unmet need for #rcc Which #biomarkers for #immunotherapy in advanced renal cell carcinoma? ⚠️ Out now our work just published on Nature Reviews Urology Thanks to my terrific GU Team 🙏 veronica mollica OncoAlert OncoNetwork Uromigos UroToday.com


‼️Just Out‼️One more masterpiece of MOUSEION Project. SR and Meta-Analysis with mRCC patients evaluating the oncologic outcomes with ICI-Combos according to metastatic sites. Congrats all authors Andrey Soares Francesco Massari Matteo Santoni veronica mollica link.springer.com/article/10.100…


⚠️📢 Which is the best treatment for mrcc good risk? Out now our research by ARON project GU Oncology Now Oncoinfo Kidney Cancer OncoNetwork


Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma. Out now on Cancer Treatment Reviews. Special Thanks to Sumanta K. Pal, MD, FASCO for the precious support. ESMO - Eur. Oncology Matteo Santoni veronica mollica Kidney Cancer AIOM


Is ICI+TKI better than Sunitinib in fav-risk #mRCC? In the abscense of biomarkers, this RWE gives us some insights into which patient should receive each treatment Fernando Sabino, MD, PhD Francesco Massari Matteo Santoni Javier Molina Cerrillo ARON project


Could the use of PPI, ATB, Insulin and Corticosteroids impair the outcomes of mUC patients during EV txt? Just out our RWE addressing this practice issue! ARON project Matteo Santoni Francesco Massari Shilpa Gupta Andrey Soares Martín Angel Maite Bourlon link.springer.com/content/pdf/10…


‼️Just Out at CancerMedicine ‼️one more piece of ARON project . RWE showing the efficacy of EV in heavily treated mUC patients. Matteo Santoni Francesco Massari Andrey Soares Shilpa Gupta Enrique Grande Maite Bourlon Javier Molina Cerrillo Lazar Popovic onlinelibrary.wiley.com/doi/10.1002/ca…



The value of molecular features in predicting efficacy of immuno-combinations in kidney cancer: just a drop in the ocean? Out now our editorial Università di Bologna



#AI🤖is reshaping #kidneycancer, but it can’t replace the human touch. Incredible and touching lecture by Matteo Santoni, leader of the #AIRON group Marco Maruzzo Massari Enrique Grande KidneyCAN IKCC Kidney Cancer Kidney Cancer This image says it all. ❤️🩹 UroFocus OncoDaily


Impressive GU Cancer Translational Research Disease Group Meeting today speaking about ARON project Thanks to Liang Cheng, MD and all colleagues from Brown University for the invitation. Matteo Santoni

🚨Just Out Our RWE. The efficacy and safety of Pembro+Len in mRCC patients of our daily practice. Interesting and very helpful data.ARON project Matteo Santoni Francesco Massari Camillo Porta Andrey Soares Maite Bourlon Enrique Grande link.springer.com/article/10.100…


1st International ARON Meeting. An impressive moment of discussion full of ideas between brilliant professionals and friends. Thanks to the ARON project and to Matteo Santoni for the precious support. Let's keep dreaming and see you at the next appointment at ESMO - Eur. Oncology


Congrats Matteo Santoni and Francesco Massari 4 ARON project – you made the unimaginable happen!🎆Bringing together people from all over the world🌍,united by passion and the drive to answer important questions. Proud to have been part of it OncoDaily IBCG associazionepalinuro


Pembro/Axi vs. Nivo/Cabo as first-line therapy in mRCC patients. Out now another important experience by ARON project OncoDaily IKCC Kidney Cancer Kidney Cancer


Thanks to Maite Bourlon for presenting ARON project at #ASCO2025 Oncoinfo OncoDaily ESMO - Eur. Oncology

Francesco Massari ARON project Oncoinfo OncoDaily ESMO - Eur. Oncology Matteo Santoni It is wonderful project with global impact !!! Francesco Massari Shilpa Gupta Enrique Grande Fernando Sabino, MD, PhD OncoAlert Tres Uramigas Andrey Soares Martín Angel

Global Oncology voices #ASCO25 @asco 🟢GO is a nascent field & embraces inclusion 🟡 Networking w international colleagues is paramount 🟠 Mentoring w a GO perspective is key 🔴 Take advantage Conquer Cancer, the ASCO Foundation opportunities 🔵 Tailor, adapt & customize to the resource setting
